XML 46 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
OPERATING ACTIVITIES:    
Net loss $ (5,402,277) $ (1,422,890)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on disposal and impairment of available-for-sale securities 42,821
Loss on derivative liability 350,969
Depreciation $ 10,809 659
Amortization 29,699 19,963
Stock based compensation 3,476,723 348,334
Changes in current assets and liabilities:    
Accounts receivable 26,199 5,566
Inventory (193,870) (53,347)
Prepaid expenses and other current assets (16,344) (16,096)
Accounts payable and accrued expense 111,430 (163,252)
Due from related party (2,181) 22,728
Deferred revenue 129,575 142,355
Net cash used in operating activities $ (1,830,237) (722,190)
INVESTING ACTIVITIES:    
Cash paid on business combination, net (304,639)
Cash from reverse merger 1,629,263
Cash from sales of available-for-sale securities $ 168,704
Cash paid on asset acquisition $ (200,000)
Purchase of furniture and equipment (89,912) $ (16,726)
Net cash (used in) provided by investing activities $ (289,912) 1,476,602
FINANCING ACTIVITIES:    
Proceeds from warrant exercises 17,000
Proceeds from Series F preferred stock issued for cash 822,750
Proceeds from common stock issued for cash 653,327
Redemption of Series B-1 preferred stock $ (350,000)
Proceeds from Series G preferred stock issued for cash $ 985,725
Net cash provided by financing activities 985,725 $ 1,143,077
NET (DECREASE) INCREASE IN CASH (1,134,424) $ 1,897,489
CASH, beginning of period 1,369,896
CASH, end of period 235,472 $ 1,897,489
Cash paid during the quarters ended September 30:    
Interest $ 404 2,239
Income taxes 3,258
Noncash investing and financing activities for the quarters ended September 30:    
Cashless exercise of Series E preferred stock attached warrants 37
Derivative liability written off to APIC due to warrant exercise 2,510,793
Conversion of Series A preferred stock to common stock $ 44 $ 1,368
Conversion of Series B preferred stock to common stock
Conversion of Series C preferred stock to common stock $ 8 $ 96
Conversion of Series D preferred stock to common stock 35
Conversion of Series E preferred stock to common stock $ 5
Reverse merger adjustment $ (2,116,221)
Deemed dividend beneficial conversion feature on convertible preferred stock 192,558
Business combination adjustment $ 79,000
Asset acquisition for stock $ 1,260,000